| 39th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis, and Immunology | |
|
null |
|
| Hosted by: | Harvard Medical School |
| Venue: | Virtual |
| Dates: | Oct 28, 2024 through Oct 31, 2024 |
| Event Registration: | 2024-05-01 through 2024-10-27 |
| Early Registration Deadline: | 2024-09-20 |
|
Description |
|
| 2024 Virtual Tumor Course Monday, October 28, 2024 – Thursday, October 31 2024 39TH CRITICAL ISSUES IN TUMOR MICROENVIRONMENT, ANGIOGENESIS, METASTASIS AND IMMUNOLOGY For comprehensive information about this course, including faculty, schedule, and pricing, please visit the 39th Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology website The “39th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis, immunology. This will include chimeric antigen receptor (CAR) T-cell therapies, tumor metabolism, and the role of microbiome. This year, we will include two new lectures on cancer neuroscience and the use of Artificial Intelligence for cancer research. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development. The course will continue its four-day online webinar-based live lecture format. Learning formats will include didactic lectures, Q&A and group case discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in the establishment of novel therapy approaches and biomarkers to guide treatment. The aim of this course remains to analyze and synthesize the most up-to-date findings. Faculty will present valuable information in a systematic and comprehensive framework and critically review the latest techniques. This course is dedicated to helping to improve the clinical translation of this knowledge and competence, leading to improved cancer treatment. We look forward to having you join us for the 39th year! Harvard Medical School’s secure registration site: https://cmeregistration.hms.harvard.edu/event/78f4e4ea-3f1c-4b89-b0b4-275040c88ea0/register |
|
| Additional Information | |
| Event URL: | https://steelelabs.mgh.harvard.edu/tumorcourse |
| ISCB Member Discount: | None |
| Contact Person: | Taylor Uccello ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
